Kuangli Bio-Tech Holdings Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 57.12 million compared to TWD 112.46 million a year ago. Net loss was TWD 33.02 million compared to TWD 5.03 million a year ago. Basic loss per share from continuing operations was TWD 0.58 compared to TWD 0.09 a year ago. Diluted loss per share from continuing operations was TWD 0.58 compared to TWD 0.09 a year ago. Basic loss per share was TWD 0.58 compared to TWD 0.09 a year ago. Diluted loss per share was TWD 0.58 compared to TWD 0.09 a year ago.
For the nine months, sales was TWD 217 million compared to TWD 234.57 million a year ago. Net loss was TWD 68.06 million compared to TWD 58.96 million a year ago. Basic loss per share from continuing operations was TWD 1.19. Diluted loss per share from continuing operations was TWD 1.19. Basic loss per share was TWD 1.19 compared to TWD 1.05 a year ago. Diluted loss per share was TWD 1.19 compared to TWD 1.05 a year ago.